Behavioral Intervention for Celiac Disease
Launched by CHILDREN'S NATIONAL RESEARCH INSTITUTE · Jan 19, 2022
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Celiac Disease (CD) is an increasingly common disease with significant morbidities if treatment is not achieved. The incidence and prevalence of CD has been increasing in children and teens over the past 15 years in the United States, with prevalence rates nearly tripling from approximately one in 133 to one in fifty children, according to regional population cohort studies. Untreated CD is associated with risks for non-Hodgkin's lymphoma, intestinal cancers, inflammatory bowel disease, diabetes mellitus, and a twofold increase in risks for mortality. The only treatment for CD is a strict G...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Teens with a physician- confirmed CD diagnosis and one parent or guardian.
- • 2. Teens 12-16 years at the time of enrollment.
- • 3. Proficient in written and spoken English.
- • 4. Have regular access to a device enabled for video conferencing (Zoom) and receiving SMS messages.
- Exclusion Criteria:
- • 1. The teen's CD diagnosis is questioned or revoked at any time during the study period;
- • 2. Another member of their household is already enrolled in the study;
- • 3. The teen has a developmental disability or major neuropsychological condition that, in the opinion of the investigators, would impair communication and engagement with the other participants and intervention material.
About Children's National Research Institute
Children's National Research Institute is a leading pediatric research organization dedicated to advancing the understanding and treatment of childhood diseases. As an integral part of Children's National Hospital, the institute focuses on innovative clinical trials and translational research that aim to improve health outcomes for children. Through collaborations with academic institutions, industry partners, and community organizations, the institute fosters a multidisciplinary approach to research, emphasizing safety, ethical standards, and the integration of cutting-edge technology in pediatric care. With a commitment to addressing the unique health challenges faced by children, Children's National Research Institute strives to translate research findings into effective therapies and interventions that enhance the quality of life for young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
District Of Columbia, District Of Columbia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials